Browsing: Lillys

By Bhanvi Satija (Reuters) -The U.S. Food and Drug Administration on Friday approved Eli Lilly’s (NYSE:) weight-loss treatment Zepbound for…

Investing.com — Eli Lilly & Co. (NYSE:) plans to begin selling its popular weight-loss drug, Mounjaro, in Hong Kong by…

Shares in Novo Nordisk (NYSE:), the Denmark-based maker of the obesity drug Wegovy, fell 1.8% in premarket trading Tuesday after…

SHANGHAI (Reuters) -Eli Lilly said on Tuesday its diabetes drug tirzepatide has received approval from Chinese regulators, increasing competition with…